| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Didi Chuxing | Transportation Ridesharing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | ServiceTitan | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $4.38B | Series H-1 | 4/19/2024 | $24.04M | $7.55B | $84.57 | Undisclosed Investors | ||||
 | Figma | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $330.25M | Series E | 6/23/2021 | $197.57M | $9.99B | $21.30 | Durable Capital Partners, Morgan Stanley | ||||
 | Netskope | Enterprise Software Cybersecurity | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.05B | Series H | 7/9/2021 | $300M | $7.5B | $20.45 | ICONIQ Capital, Lightspeed Venture Partners, Accel, Sequoia Capital, Base Partners, Sapphire Ventures, Geodesic Capital | ||||
 | Insilico Medicine | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Klaviyo | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $520M | Not available | -- | -- | -- | -- | -- | ||||
 | Parabilis Medicines | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $811.88M | Series F | 1/8/2026 | $305.25M | $681.2M | $6.16 | RA Capital Management, Fidelity, Janus Henderson Investors, Frazier Life Sciences, Soleus Capital, venBio Partners, Cormorant Asset Management, Nextech Invest, ARCH Venture Partners, Milky Way Investments, GV, T. Rowe Price, Marshall Wace, General Catalyst, Invus, Farallon Capital Management, Foresite Capital, Rock Springs Capital, HBM Healthcare Investments, Samsara BioCapital, Catalio Capital Management, Sixty Degree Capital, Alderline Group | ||||
 | Wealthfront | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $300.01M | Series H-2 | 9/2/2022 | $34.85M | $1.4B | $9.54 | UBS | ||||
 | Astera Labs | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $711.38M | Series D | 11/17/2022 | $150M | $3.16B | $20.34 | Fidelity, Atreides Management, Intel Capital, Sutter Hill Ventures | ||||
 | MNTN | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $358.43M | Series D | 2/1/2022 | $119M | $2.21B | $22.97 | BlackRock, Fidelity | ||||
 | Navan | Enterprise Software Business Operations | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.3B | Series G | 10/12/2022 | $100M | $9.2B | $37.45 | Andreessen Horowitz, Premji Invest, Base Partners, Elad Gil, Greenoaks Capital, Zeev Ventures, Lightspeed Venture Partners, Addition Ventures | ||||
 | X-energy | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.93B | Series D | 11/24/2025 | $699.69M | $5.06B | $14.53 | Jane Street, ARK Invest, Galvanize, Hood River Capital Management, Point72, Reaves Asset Management, XTX Ventures, Ares Management, Corner Capital, Emerson Collective, NGP Energy Capital Management, Segra Capital Management, Gorilla Private Equity, Litquidity Capital, Stack Capital Group, The Venture Collective | ||||
 | Hinge Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $2.54B | Series E | 10/28/2021 | $400M | $6.2B | $77.46 | Coatue Management, Tiger Global Management | ||||
 | Instacart | Transportation Delivery Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $2.66B | Series I | 2/26/2021 | $136.36M | $39.13B | $125.00 | Andreessen Horowitz, Sequoia Capital, D1 Capital Partners, Fidelity, T. Rowe Price Associates | ||||
 | MBX Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $216.64M | Series C | 8/5/2024 | $63.5M | $316.71M | $1.03 | Deep Track Capital, Driehaus Capital Management, T. Rowe Price Associates, Frazier Life Sciences, OrbiMed, Wellington Management | ||||
 | Prime Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $315.76M | Series B | 7/13/2021 | $200M | $1.23B | $4.38 | ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, Public Sector Pension Investment Board, Redmile Group, Samsara BioCapital, T. Rowe Price | ||||
 | Ather Energy | Transportation Electric Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Aura | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $496.54M | Series G | 3/24/2025 | $89.65M | $1.6B | $10.28 | Ten Eleven Ventures, Madrone Capital, AT&T Ventures, Accel, Warburg Pincus, General Catalyst | ||||
 | Cava | Consumer & Lifestyle Restaurants & Coffee | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.64B | Series F | 4/27/2021 | $212M | $1.39B | $12.54 | T. Rowe Price Group, Equilibra Partners Management, Lighthouse Investment Partners, Declaration Partners | ||||
 | Klarna | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $4.04B | Not available | -- | -- | -- | -- | -- | ||||
 | Liftoff Mobile | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Tempus | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $3.06B | Series G-5 | 4/30/2024 | $200M | $8.89B | $57.31 | Softbank | ||||
 | Aura Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $225.08M | Series E | 3/22/2021 | $80.48M | $283.03M | $0.78 | Matrix Capital Management, Surveyor Capital, Rock Springs Capital, Adage Capital Management LP, Velosity Capital, Medicxi, Advent Life Sciences, Lundbeckfonden Ventures, Arix Bioscience, Chiesi Ventures, Ysios Capital, Columbus Venture Partners | ||||
 | HeartFlow | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $755.52M | Series F | 4/6/2023 | $174.86M | $546.5M | $2.85 | Bain Capital, Janus Henderson Investors, Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP, Wellington Management | ||||